Enjoy complimentary customisation on priority with our Enterprise License!
The emergence of advanced diagnostic techniques such as the use of biomarkers for diagnosing pneumonia has improved the identification rate of respiratory infections. The molecular diagnostic technique aids in understanding the outbreak and transmission of disease. Technavio’s market research study has identified the emergence of advanced diagnostic techniques to be one of the primary factors fueling the growth of the pneumonia therapeutics market in the coming years. The emergence of advanced diagnosis provides various benefits such as improved organism quantification, differentiation, and typing and profiling of antibiotic resistance. With the growing need for early and precise diagnosis there is an increasing demand for drugs to treat pneumonia, which in turn, fuels market growth. Our market research analysts have estimated that this market will grow steadily at a CAGR of almost 7% by 2021.
There is an increasing prevalence of respiratory tract infections such as community-acquired pneumonia (CAP) and ventilator-associated pneumonia (VAP). CAP is one of the major causes of mortality and morbidity and the increase in such cases is mainly due to the rising concerns about antibiotic resistance. This induces the need for clinical studies for the treatment of CAP and VAP, which further contributes to the demand for pneumonia therapeutic drugs. According to our analysts, the rise in respiratory infection cases will be one of the key trends a that will have a positive impact on the pneumonia therapeutics market in the coming years.
The pneumonia therapeutics market is moderately fragmented owing to the presence of several international, regional, and local vendors. Key vendors in this pneumonia treatment market are investing heavily in R&D to innovate novel drugs. To strengthen their market positions, the players in the pneumonia therapeutics market are following strategic activities such as M&A.
The leading vendors in the market are
The other vendors in the market are AstraZeneca, Bayer, Biotest, Ono Pharmaceutical, and Tetraphase Pharmaceuticals.
The vaccine segment accounts for major share of the pneumonia treatment market due to its high efficiency in the prophylaxis of pneumonia and its cost-effectiveness. The high annual cost for drug therapy and the increased awareness and need for the prevention of pneumonia, will contribute to the growth of the pneumonia therapeutics market in this segment.
The Americas will be the major revenue contributor to the pneumonia therapeutics market due to the availability of an excellent infrastructure and the presence of developed economies. This region consists of several major key players that are actively engaged in launching new and innovative products. Additionally, the increasing health awareness and the initiatives taken for the prevention of pneumonia will further contribute to the growth of the pneumonia treatment market in this region.
Technavio also offers customization on reports based on specific client requirement.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
PART 05: DISEASE OVERVIEW
PART 06: MARKET ECOSYSTEM
PART 07: MARKET SIZING
PART 08: PIPELINE ANALYSIS
PART 09: FIVE FORCES ANALYSIS
PART 10: MARKET SEGMENTATION BY PRODUCT TYPE
PART 11: MARKET SEGMENTATION BY PNEUMONIA TYPE
PART 12: REGIONAL LANDSCAPE
PART 13: DECISION FRAMEWORK
PART 14: DRIVERS AND CHALLENGES
PART 15: MARKET TRENDS
PART 16: VENDOR LANDSCAPE
PART 17: VENDOR ANALYSIS
PART 18: APPENDIX
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.